Literature DB >> 18493870

Microinvasive carcinoma of the breast.

Simonetta Bianchi1, Vania Vezzosi.   

Abstract

The increased rate of early detection of breast cancer due to widespread mammographic screening has led to an increased incidence not only of in situ but also microinvasive carcinoma (MC). MC has been reported to have a favourable prognosis, but specific definitions have varied in the past making the clinical significance of this entity a subject of debate. In fact, although the diagnosis of MC often appears in pathology reports, this term has not been used in a consistent, standardized manner. In addition, the histological diagnosis of MC can be problematical for the pathologist due to a variety of in situ patterns and artefacts that may be misinterpreted as stromal invasion. Definitions and diagnostic criteria of MC are reviewed and discussed. Based on a review of literature, incidence of axillary lymph node involvement, according to different definitions of microinvasion, is reported.

Entities:  

Mesh:

Year:  2008        PMID: 18493870     DOI: 10.1007/s12253-008-9054-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  43 in total

1.  Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study.

Authors:  S Damiani; M Ludvikova; G Tomasic; S Bianchi; A M Gown; V Eusebi
Journal:  Virchows Arch       Date:  1999-03       Impact factor: 4.064

2.  Pathology reporting in breast cancer screening. Royal College of Pathologists Working Group.

Authors: 
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

3.  Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease.

Authors:  M E Schuh; T Nemoto; R B Penetrante; D Rosner; T L Dao
Journal:  Arch Surg       Date:  1986-11

4.  Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.

Authors:  M Leidenius; K Salmenkivi; K von Smitten; P Heikkilä
Journal:  J Surg Oncol       Date:  2006-10-01       Impact factor: 3.454

5.  Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.

Authors:  R F Padmore; B Fowble; J Hoffman; C Rosser; A Hanlon; A S Patchefsky
Journal:  Cancer       Date:  2000-03-15       Impact factor: 6.860

6.  Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

Authors:  N Klauber-DeMore; L K Tan; L Liberman; S Kaptain; J Fey; P Borgen; A Heerdt; L Montgomery; M Paglia; J A Petrek; H S Cody; K J Van Zee
Journal:  Ann Surg Oncol       Date:  2000-10       Impact factor: 5.344

7.  Sentinel lymph node metastasis in microinvasive breast cancer.

Authors:  Mattia Intra; Stefano Zurrida; Fausto Maffini; Angelica Sonzogni; Giuseppe Trifirò; Roberto Gennari; Paolo Arnone; Guillermo Bassani; Antonio Opazo; Giovanni Paganelli; Giuseppe Viale; Umberto Veronesi
Journal:  Ann Surg Oncol       Date:  2003-12       Impact factor: 5.344

8.  Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures.

Authors:  M D Lagios; P R Westdahl; F R Margolin; M R Rose
Journal:  Cancer       Date:  1982-10-01       Impact factor: 6.860

Review 9.  In situ and invasive lobular neoplasia of the breast.

Authors:  A M Hanby; T A Hughes
Journal:  Histopathology       Date:  2008-01       Impact factor: 5.087

Review 10.  Surgical treatment of ductal carcinoma in situ of the breast. 10- to 20-year follow-up.

Authors:  T Simpson; R C Thirlby; D H Dail
Journal:  Arch Surg       Date:  1992-04
View more
  23 in total

1.  Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers.

Authors:  G Cserni; C A Wells; H Kaya; P Regitnig; A Sapino; G Floris; T Decker; M P Foschini; P J van Diest; D Grabau; A Reiner; J DeGaetano; E Chmielik; A Cordoba; X Andreu; V Zolota; E Charafe-Jauffret; A Ryska; Z Varga; N Weingertner; J P Bellocq; I Liepniece-Karele; G Callagy; J Kulka; H Bürger; P Figueiredo; J Wesseling; I Amendoeira; D Faverly; C M Quinn; S Bianchi
Journal:  Virchows Arch       Date:  2016-01-27       Impact factor: 4.064

2.  Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.

Authors:  Naoko Mori; Hideki Ota; Shunji Mugikura; Chiaki Takasawa; Junya Tominaga; Takanori Ishida; Mika Watanabe; Kei Takase; Shoki Takahashi
Journal:  Eur Radiol       Date:  2013-06-04       Impact factor: 5.315

3.  Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.

Authors:  Michael J Campbell; Frederick Baehner; Tess O'Meara; Ekene Ojukwu; Booyeon Han; Rita Mukhtar; Vickram Tandon; Max Endicott; Zelos Zhu; Jasmine Wong; Gregor Krings; Alfred Au; Joe W Gray; Laura Esserman
Journal:  Breast Cancer Res Treat       Date:  2016-10-26       Impact factor: 4.872

4.  Incidence, characteristics, and management of recently diagnosed, microscopically invasive breast cancer by receptor status: Iowa SEER 2000 to 2013.

Authors:  Alexandra Thomas; Ronald J Weigel; Charles F Lynch; Philip M Spanheimer; Elizabeth K Breitbach; Mary C Schroeder
Journal:  Am J Surg       Date:  2016-09-02       Impact factor: 2.565

5.  Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases.

Authors:  Cindy B Matsen; Allison Hirsch; Anne Eaton; Michelle Stempel; Alexandra Heerdt; Kimberly J Van Zee; Hiram S Cody; Monica Morrow; George Plitas
Journal:  Ann Surg Oncol       Date:  2014-08-05       Impact factor: 5.344

6.  Second harmonic generation reveals matrix alterations during breast tumor progression.

Authors:  Kathleen Burke; Ping Tang; Edward Brown
Journal:  J Biomed Opt       Date:  2013-03       Impact factor: 3.170

7.  Breast ductal Carcinoma in situ associated with microinvasion induces immunological response and predicts ipsilateral invasive recurrence.

Authors:  Xiao-Yang Chen; Aye Aye Thike; Valerie Cui Yun Koh; Nur Diyana Md Nasir; Boon Huat Bay; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2020-11-02       Impact factor: 4.064

Review 8.  A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer.

Authors:  J A Glover; C M Hughes; M M Cantwell; L J Murray
Journal:  Br J Cancer       Date:  2011-06-07       Impact factor: 7.640

9.  Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma.

Authors:  Xing Hua; Lina Yu; Xiaoxiao Huang; Zexiao Liao; Qi Xian
Journal:  Diagn Pathol       Date:  2011-11-08       Impact factor: 2.644

10.  Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer.

Authors:  Wei Zhang; Er-li Gao; Yi-li Zhou; Qi Zhai; Zhang-yong Zou; Gui-long Guo; Guo-rong Chen; Hua-min Zheng; Guan-li Huang; Xiao-hua Zhang
Journal:  World J Surg Oncol       Date:  2012-12-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.